HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
Technically Speaking
|
May 2019
Technically Speaking
Monthly Column by Deborah Wexler, MD
Deborah Wexler MD
Technically Speaking is a monthly column written by IAC’s Executive Director Deborah Wexler, MD. The column is featured in The Children's Hospital of Philadelphia Vaccine Education Center’s (VEC's) monthly e-newsletter for healthcare professionals. Technically Speaking columns cover practical topics in immunization delivery such as needle length, vaccine administration, cold chain, and immunization schedules.
Check out a recent issue of Vaccine Update for Healthcare Providers. The VEC e-newsletter keeps providers up to date on vaccine-related issues and includes reviews of recently published journal articles, media recaps, announcements about new resources, and a regularly updated calendar of events.
TECHNICALLY SPEAKING
How to Protect Children, Adults, and Healthcare Personnel from Measles
Published May 2019
In the U.S., we are currently experiencing measles outbreaks in 23 states, with 839 individual cases confirmed between January 1 and May 10, 2019. This is the greatest number of cases reported in the U.S. in a single year since 1994 and since measles was declared eliminated in 2000. Most of the people getting infected are unvaccinated.

Many vulnerable people in our communities are unvaccinated because they are too young for vaccination or have medical conditions like cancers and immune system disorders for which MMR vaccination is contraindicated. For their protection, these individuals must rely on those around them having high MMR vaccination coverage rates.

We can help stop these outbreaks and heighten community immunity. Make sure your patients, their families, and healthcare personnel (HCP) are protected by following the measles vaccination recommendations of CDC's Advisory Committee on Immunization Practices (ACIP), briefly described below.

Protecting Children from Measles

Two doses of MMR vaccine are routinely recommended for children. The first dose is given at age 12–15 months and the second dose at age 4–6 years. But instead of waiting until age 4–6 years, the second dose may be given as soon as 4 weeks (28 days) after the first dose and still be counted as a valid dose if both doses were given after the child's first birthday. Giving the second dose as early as 4 weeks after the first dose should be considered in communities where measles is circulating. The second dose is not a booster, but rather is intended to produce immunity in the small number of people who fail to respond to the first dose.

MMR vaccine may be administered to infants as young as age 6–11 months who are at high risk of exposure. This includes international travelers, as well as infants living in communities experiencing measles outbreaks. Consult your local or state health department to find out if this is recommended in your community. If you give a dose of MMR vaccine to an infant before the first birthday, it does not count as part of the routine 2-dose MMR series. The first dose should be repeated when the child is age 12 months.

Protecting Adults from Measles

For adults born before 1957

Adults born before 1957 can be assumed to be immune to measles. This includes international travelers and students, but it does not necessarily apply to healthcare personnel (HCP). Healthcare facilities should consider vaccinating unvaccinated HCP born before 1957 who do not have laboratory evidence of measles immunity, laboratory confirmation of disease, or vaccination with 2 appropriately spaced doses of MMR vaccine. CDC recommends that, during an outbreak of measles, healthcare facilities should recommend 2 doses of MMR vaccine at the appropriate interval for unvaccinated HCP who lack laboratory evidence of measles immunity, regardless of birth year.

For adults born in 1957 or later

Adults born in 1957 or later should receive at least 1 dose of MMR vaccine unless they have acceptable evidence of immunity (i.e., 1 documented dose of MMR or a measles-containing vaccine, laboratory evidence of immunity, or laboratory confirmation of disease).

Certain adults born in 1957 or later may need 2 doses. Adults who are going to be in a setting that poses a high risk for measles transmission should make sure they have had 2 doses separated by at least 28 days. These adults include:

  • students at post-high school education institutions;
  • healthcare personnel;
  • international travelers; and
  • people who public health authorities determine are at increased risk for getting measles during a measles outbreak.

People who previously received a dose of MMR vaccine between 1963–1967 and are unsure which type of vaccine (live or inactivated measles vaccine) was used, or who are sure it was inactivated measles vaccine, should be revaccinated with either 1 dose (if low risk) or 2 doses (if high risk) of MMR vaccine.

If a person born in 1957 or later has no documentation of MMR, you could check the patient's blood for a measles titer; however, commercial tests currently available are not sensitive enough to reliably detect vaccine-induced immunity, leading to false negatives. In addition, this step will require an extra office visit and add to the cost. There is no harm in receiving 1 or 2 doses of MMR vaccine if a person is already immune to measles (or mumps or rubella). ACIP does not recommend testing for immunity after appropriate MMR vaccination.

On May 17, CDC released a "Dear Provider" letter discussing what clinicians need to know about protecting adult patients from measles.

During this time of outbreaks in so many states with case counts climbing week after week, it's important to make sure your patients are protected from this highly contagious virus.

References

2019 ISSUES >> view all issues
DECEMBER 2019
ACIP Updates Its Pneumococcal Vaccine Recommendations for Adults Age 65 Years and Older
NOVEMBER 2019
ACIP Votes to Approve That Tdap and Td Vaccines May Now Be Used Interchangeably
OCTOBER 2019
CDC Updates Recommendations on the Use of HPV Vaccine
SEPTEMBER 2019
"Dear Colleague" Call-to-Action Letter from AAFP, AAP, ACHA, ACOG, APhA, SAHM, and IAC Stresses Importance of Implementing Immunization Visit at 16 Years of Age
AUGUST 2019
Newly Designed and Easy to Navigate—Visit Give2MenACWY.org to Enhance Your Efforts to Increase Rates for MenACWY Booster Doses and Other Adolescent Vaccinations
JULY 2019
ACIP Updates Its Guidance on the Use of HPV, PCV13, HepA, HPV, and MenB Vaccines at June 26–27 Meeting
JUNE 2019
Looking for New Tools and Resources to Help Increase Your Clinic's HPV Vaccination Rates? Here Are Some Great Ones!
MAY 2019
How to Protect Children, Adults, and Healthcare Personnel from Measles
APRIL 2019
Refresher! Use of Pneumococcal Vaccines in Infants and Children, as well as in Children with Health Conditions
MARCH 2019
With Measles "Breaking Out" All over the United States, Here Are Some Good Educational Resources
FEBRUARY 2019
Questions about Proper Vaccine Storage and Handling? CDC's Redesigned Toolkit Has Answers!
JANUARY 2019
Want to Avoid Vaccination Errors? These Print Materials and Slide Sets Will Help You!
    >> view all issues
 
This page was updated on May 23, 2019.
This page was reviewed on May 23, 2019.
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Vaccination and COVID-19
Vaccine Recommendations
Vaccine Storage & Handling
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IAC EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Q&As: Easy-to-Read
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IAC EXPRESS
Subscribe to IAC Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POWERPOINT SLIDE SETS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
SLIDE SETS
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IAC EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
Hepatitis B
HPV (Human papillomavirus)
Influenza
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.